FR2408581B1 - - Google Patents

Info

Publication number
FR2408581B1
FR2408581B1 FR7804598A FR7804598A FR2408581B1 FR 2408581 B1 FR2408581 B1 FR 2408581B1 FR 7804598 A FR7804598 A FR 7804598A FR 7804598 A FR7804598 A FR 7804598A FR 2408581 B1 FR2408581 B1 FR 2408581B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7804598A
Other versions
FR2408581A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of FR2408581A1 publication Critical patent/FR2408581A1/fr
Application granted granted Critical
Publication of FR2408581B1 publication Critical patent/FR2408581B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7804598A 1977-11-15 1978-02-17 Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant Granted FR2408581A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85177877A 1977-11-15 1977-11-15

Publications (2)

Publication Number Publication Date
FR2408581A1 FR2408581A1 (fr) 1979-06-08
FR2408581B1 true FR2408581B1 (fr) 1983-07-22

Family

ID=25311658

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7804598A Granted FR2408581A1 (fr) 1977-11-15 1978-02-17 Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant

Country Status (7)

Country Link
JP (2) JPS5476522A (fr)
BE (1) BE864122A (fr)
CA (1) CA1105923A (fr)
CH (1) CH640217A5 (fr)
DE (1) DE2804567C2 (fr)
FR (1) FR2408581A1 (fr)
SE (1) SE446866B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
JPH0528542U (ja) * 1991-04-03 1993-04-16 品川白煉瓦株式会社 連続鋳造用ロングノズル
ATE380342T1 (de) * 2001-05-07 2007-12-15 Hipep Lab Peptidimmobilisierte grundplatte und vefahren zum testen eines zielproteins unter verwendung derselben

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use

Also Published As

Publication number Publication date
DE2804567C2 (de) 1986-01-16
JPS5476522A (en) 1979-06-19
CA1105923A (fr) 1981-07-28
BE864122A (fr) 1978-08-21
JPS6149320B2 (fr) 1986-10-29
CH640217A5 (en) 1983-12-30
JPS6150999A (ja) 1986-03-13
JPH0137400B2 (fr) 1989-08-07
DE2804567A1 (de) 1979-05-17
SE7801031L (sv) 1979-05-16
SE446866B (sv) 1986-10-13
FR2408581A1 (fr) 1979-06-08

Similar Documents

Publication Publication Date Title
FR2377485B1 (fr)
FR2375830B3 (fr)
DE2822153C2 (fr)
FR2377524B1 (fr)
DE2760342A1 (fr)
DE2831867C2 (fr)
AU3353778A (fr)
AU495917B2 (fr)
AR210643A1 (fr)
AU71461S (fr)
DK528977A (fr)
BG25810A1 (fr)
BG25823A1 (fr)
BE871991A (fr)
BE872973A (fr)
BE873002A (fr)
BG23438A1 (fr)
BG23462A1 (fr)
BE870787A (fr)
BG24331A1 (fr)
BG24713A1 (fr)
BG25808A1 (fr)
BG25809A1 (fr)
BG25813A1 (fr)
BG25811A1 (fr)